New research has determined that classic psychedelics including psilocybin and LSD are well tolerated in research and clinical settings, with rare adverse events occurring. For their study, the ...

Irish psychedelic biotech firm GH Research PLC (NASDAQ: GHRS) reported on Tuesday financial results for the second quarter ...

Part 2 of the study will investigate a single dose of BPL-003 in patients who are BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered ...

With animated sequences and intimate profiles, 'Athlete A' directors Jon Shenk and Bonni Cohen’s latest is another heartfelt look at a pressing social issue. Those would be ibogaine and 5-MeO-DMT.

While psychedelics like LSD and psilocybin are generally well tolerated in clinical and research settings, study authors ...

Projected commercialization of COMP360 for TRD in 2-3 years. Two patent-protected programs BPL-003 (intranasal 5-MeO-DMT for Treatment Resistant Depression (TRD) and Alcohol Use Disorder (AUD ...

UK-company Beckley Psytech has initiated a phase IIa trial in its synthetic 5-MeO-DMT (or Mebufotenin) candidate, BPL-003, as a treatment for TRD, exploring the safety, efficacy, and ...

N-dimethyltryptamine (5-MeO-DMT, or Mebufotenin) that is currently being explored as a potential therapeutic for Treatment Resistant Depression (TRD). It will also suppor thte advancement of ELE ...